The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_000018.4(ACADVL):c.770del (p.Asp257fs)

CA981153094

935797 (ClinVar)

Gene: ACADVL
Condition: very long chain acyl-CoA dehydrogenase deficiency
Inheritance Mode: Autosomal recessive inheritance
UUID: c6f69535-1a12-44ac-9112-2dbc55515d3e

HGVS expressions

NM_000018.4:c.770del
NM_000018.4(ACADVL):c.770del (p.Asp257fs)
NC_000017.11:g.7222194del
CM000679.2:g.7222194del
NC_000017.10:g.7125513del
CM000679.1:g.7125513del
NC_000017.9:g.7066237del
NG_007975.1:g.7361del
NG_008391.2:g.2857del
ENST00000356839.10:c.770del
ENST00000322910.9:c.*725del
ENST00000350303.9:c.704del
ENST00000356839.9:c.770del
ENST00000543245.6:c.839del
ENST00000577191.5:n.942del
ENST00000581378.5:n.488del
ENST00000582379.1:n.154del
NM_000018.3:c.770del
NM_001033859.2:c.704del
NM_001270447.1:c.839del
NM_001270448.1:c.542del
NM_001033859.3:c.704del
NM_001270447.2:c.839del
NM_001270448.2:c.542del

Likely Pathogenic

The Expert Panel has overridden the computationally generated classification - "Uncertain Significance - Insufficient Evidence"
Met criteria codes 2
PM2_Supporting PVS1
Not Met criteria codes 1
PP4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
ACADVL VCEP
The NM_000018.4:c.770del (p.Asp257AlafsTer19) variant in ACADVL is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 9/20 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1; PMIDs 9973285, 11590124). At least one individual with this variant was identified by newborn screen, but this information is insufficient to use toward classification (PMID: 30194637, 20547398). Additionally, this variant was identified in an individual who reportedly had increased acylcarnities and decreased very long chain acyl-CoA dehydrogenase (VLCAD) activity, but this information was insufficient to use toward classification (PMID: 12682504). This variant is absent from gnomAD v2.1.1 (PM2_supporting). In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal recessive VLCAD deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation Expert Panel: PVS1, PM2_Supporting (ACADVL VCEP specifications version 1; approved November 8, 2021).
Met criteria codes
PM2_Supporting
This variant is absent from gnomAD v2.1.1 (PM2_supporting).
PVS1
The NM_000018.4:c.770del (p.Asp257AlafsTer19) variant in ACADVL is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 9/20 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1; PMIDs 9973285, 11590124).
Not Met criteria codes
PP4
At least one individual with this variant was identified by newborn screen, but this information is insufficient to use toward classification (PMID: 30194637, 20547398). Additionally, this variant was identified in an individual who reportedly had increased acylcarnities and decreased very long chain acyl-CoA dehydrogenase (VLCAD) activity, but this information was insufficient to use toward classification (PMID:12682504).
Approved on: 2023-01-10
Published on: 2023-01-10
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.